Evaluation of an Online Educational Child Injury Prevention Intervention

September 8, 2026 updated by: University of Oregon

The goal of this evaluation is to learn what effect the Safe Kids Washington website, a self-guided web-based intervention program, has on:

Parent knowledge of injury prevention strategies Parent attitudes, self-efficacy and behavioral intention regarding use of the strategies Parent satisfaction with the Safe Kids training, and Parent opinion of the Safe Kids website usability, functionality, and perceived usefulness

The program will be evaluated using a random control design. Participants are randomly assigned to either the Safe Kids Washington condition or to a control condition.

Intervention participants will:

Access three modules, focused on pedestrian safety, bicycling safety, and sports safety with an emphasis on concussion prevention watch a brief informational video with relevant statistics about the injury threat be presented with streamlined injury prevention information like how to wear a helmet correctly watch a brief animated vignette with a fictional story about injury prevention engage in interactive game-like knowledge checks like quizzes and flashcards be provided resources like factsheets, tips and guides for parents

Control participants will:

be provided access to three CDC HEADS UP fact sheets, focused on similar topics of playground safety, bike helmet safety, and concussion tips

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

203

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Oregon
      • Eugene, Oregon, United States, 97403
        • University of Oregon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • at least 18 years old
  • parent or caregiver of a child between 7 and 12 years old

Exclusion Criteria:

  • under 18 years old
  • not the parent or caregiver of a child between 7 and 12 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intervention condition
Other: Safe Kids Washington
three modules, focused on pedestrian safety, bicycling safety, and sports safety that include short informational videos, streamlined injury prevention information, animated vignettes, and interactive knowledge checks
Other Names:
  • Kid Safety Study
Other: Active Control condition
A control condition in which participants are provided text-based informational material comparable to the intervention condition content but without the additional engaging module components
Other: Active Control condition
access to three CDC HEADS UP fact sheets, focused on topics of playground safety, bike helmet safety, and concussion tips

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
perceived vulnerability
Time Frame: From pre-test to post-test (typically less than a half hour between)
From pre-test to post-test (typically less than a half hour between)
self-efficacy
Time Frame: from pre-test to post-test (typically less than a half-hour between)
from pre-test to post-test (typically less than a half-hour between)
knowledge
Time Frame: from pre-test to post-test (typically less than a half-hour between)
from pre-test to post-test (typically less than a half-hour between)
behavioral intentions
Time Frame: From pre-test to post-test (typically less than a half hour between)
From pre-test to post-test (typically less than a half hour between)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Oregon

Investigators

  • Principal Investigator: Melissa McCart, Ed.D., University of Oregon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2025

Primary Completion (Actual)

February 15, 2026

Study Completion (Actual)

February 15, 2026

Study Registration Dates

First Submitted

August 31, 2026

First Submitted That Met QC Criteria

August 31, 2026

First Posted (Actual)

September 4, 2026

Study Record Updates

Last Update Posted (Actual)

September 11, 2026

Last Update Submitted That Met QC Criteria

September 8, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00001746

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected IPD are available from the corresponding author, [M. McCart], upon reasonable request.

IPD Sharing Time Frame

Immediately upon publication and for 4 years afterward

IPD Sharing Access Criteria

Any and all requested IPD and related information like statistical methods will be provided to any reasonable request upon review by the corresponding author (M. McCart) in any format requested that can be reasonably accommodated, including emailed attachments of secured documents and common secure file sharing options like Microsoft Teams or Dropbox.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe